Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-၂.၆၉%
၁,၀၆၈.၂၄
-၂၉.၅၇
-၂.၆၉%
—၁,၀၉၇.၈၁၁,၀၈၇.၇၆၁,၀၈၇.၇၆၁,၀၆၇.၄၂——
SIXC
Communications
SIXC
Communications
SIXC
-၀.၈၉%
၆၀၆.၅၉
-၅.၄၄
-၀.၈၉%
—၆၁၂.၀၃၆၁၂.၀၃၆၁၂.၀၃၆၀၆.၁၃——
SIXE
Energy
SIXE
Energy
SIXE
+၂.၁၉%
၁,၂၄၇.၂၁
+၂၆.၇၈
+၂.၁၉%
—၁,၂၂၀.၄၃၁,၂၂၁.၉၉၁,၂၄၇.၆၀၁,၂၂၁.၉၉——
SIXI
Industrials
SIXI
Industrials
SIXI
-၁.၈၂%
၁,၇၂၇.၅၈
-၃၁.၉၄
-၁.၈၂%
—၁,၇၅၉.၅၂၁,၇၅၄.၃၁၁,၇၅၄.၃၁၁,၇၂၃.၆၀——
SIXM
Financials
SIXM
Financials
SIXM
-၀.၃၂%
၆၂၉.၅၄
-၂.၀၀
-၀.၃၂%
—၆၃၁.၅၄၆၃၁.၂၇၆၃၃.၉၉၆၂၈.၆၃——
SIXR
Staples
SIXR
Staples
SIXR
-၀.၄၂%
၈၅၃.၆၀
-၃.၅၆
-၀.၄၂%
—၈၅၇.၁၆၈၅၈.၉၁၈၆၁.၇၁၈၅၂.၃၃——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-၁.၅၆%
၂၁၂.၀၄
-၃.၃၇
-၁.၅၆%
—၂၁၅.၄၁၂၁၅.၄၁၂၁၅.၄၁၂၁၁.၈၈——
SIXT
Technology
SIXT
Technology
SIXT
-၁.၇၈%
၃,၅၄၉.၇၆
-၆၄.၃၉
-၁.၇၈%
—၃,၆၁၄.၁၅၃,၅၅၆.၂၄၃,၅၉၈.၃၆၃,၅၁၆.၈၆——
SIXU
Utilities
SIXU
Utilities
SIXU
-၂.၄၀%
၈၈၆.၄၉
-၂၁.၈၁
-၂.၄၀%
—၉၀၈.၃၀၉၀၆.၅၅၉၀၆.၅၅၈၈၅.၈၈——
SIXV
Health care
SIXV
Health care
SIXV
-၁.၀၈%
၁,၄၆၄.၃၄
-၁၆.၀၆
-၁.၀၈%
—၁,၄၈၀.၄၀၁,၄၇၉.၅၅၁,၄၈၄.၄၃၁,၄၆၂.၅၂——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-၁.၈၄%
၂,၃၅၄.၂၅
-၄၄.၁၂
-၁.၈၄%
—၂,၃၉၈.၃၇၂,၃၇၃.၀၉၂,၃၇၃.၀၉၂,၃၅၀.၂၇——
LSTA:NASDAQ
Lisata Therapeutics Inc
၃.၁၇ US$
+၂.၉၂%
(+၀.၀၉၀) 1D
၃.၁၉ US$
+၀.၆၃% (+၀.၀၂၀)
After hours
Closed: မေ ၁၅, GMT-၄ ၁၆:၀၀:၀၁  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for LSTA...
Open
၃.၀၂ US$
High
၃.၂၂ US$
Low
၃.၀၂ US$
Mkt. cap
၂.၈၉ ကုဋေ
Avg. vol.
၇.၇၇ သောင်း
Volume
၂.၃၂ သောင်း
52-wk high
၅.၀၇ US$
52-wk low
၁.၈၁ US$
EPS
-၁.၉၁ US$
Beta
၀.၈၁
Shares outstanding
၉.၁၁ သန်း
No. of employees
၂၁
News stories
From sources across the web
Investing.com
Investing.com
·
ပြီးခဲ့သည့် ၈ နာရီ
H.C. Wainwright downgrades Lisata Therapeutics stock rating to neutral
Profile
Lisata Therapeutics is an American clinical stage pharmaceutical company active in the field of oncology, specifically aimed at developing and commercializing new cancer therapies. It was formed through a merger of Cend Therapeutics and Caladrius Biosciences in September 2022. In 2019, the FDA granted their product, certepetide, orphan drug status in pancreatic cancer, followed by a Fast track status in 2022. Non-clinical data collected by Lisata and others have demonstrated enhanced delivery of various existing and emerging anti-cancer therapies, including chemotherapies, immunotherapies and RNA-based therapeutics when used with certepetide. Wikipedia
About Lisata Therapeutics Inc
CEO-
Employees၂၁
Founded၁၉၈၀
HeadquartersBasking Ridge, နယူးဂျာစီပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Websitelisata.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
၂၀၂၅ ဇွန်
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
Revenue
၇.၀၀ သောင်း
-
၁.၀၀ သိန်း
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
၂.၂၅ သန်း
၁.၉၆ သန်း
၁.၁၃ သန်း
၁.၂၀ သန်း
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၂.၆၈ သန်း
၂.၄၆ သန်း
၂.၀၄ သန်း
၃.၇၄ သန်း
Operating expense
၄.၉၄ သန်း
၄.၄၁ သန်း
၃.၁၈ သန်း
၄.၉၄ သန်း
Total operating expenses
၄.၉၄ သန်း
၄.၄၁ သန်း
၃.၁၈ သန်း
၄.၉၄ သန်း
Operating income
-၄.၈၇ သန်း
-၄.၄၁ သန်း
-၃.၀၈ သန်း
-၄.၉၄ သန်း
Other non operating income
-၇.၀၀ ထောင်
-၁.၈၀ သောင်း
-၁.၆၀ သောင်း
-၅.၄၀ သောင်း
EBT including unusual items
-၄.၆၆ သန်း
-၄.၂၅ သန်း
-၂.၉၅ သန်း
-၄.၈၈ သန်း
EBT excluding unusual items
-၄.၆၆ သန်း
-၄.၂၅ သန်း
-၂.၉၅ သန်း
-၄.၈၈ သန်း
Income tax expense
-
-
-
-၃.၈၇ သိန်း
Effective tax rate
-
-
-
၇.၉၄%
Other operating expenses
-
-
-
-
Net income
-၄.၆၆ သန်း
-၄.၂၅ သန်း
-၂.၉၅ သန်း
-၄.၄၉ သန်း
Net profit margin
-၆,၆၅၅.၇၁%
-
-၂,၉၅၄.၀၀%
-
Earnings per share
-၀.၅၄
-၀.၄၉
-
-
Interest and investment income
၂.၁၆ သိန်း
၁.၈၃ သိန်း
၁.၄၁ သိန်း
၁.၂၀ သိန်း
Interest expense
-
-
-
-
Net interest expenses
၂.၁၆ သိန်း
၁.၈၃ သိန်း
၁.၄၁ သိန်း
၁.၂၀ သိန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
-၄.၈၂ သန်း
-၄.၃၇ သန်း
-၃.၀၆ သန်း
-၄.၉၄ သန်း
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer